FDA warns of pure red cell aplasia (PRCA) with CellCept - MPR
Links shared publicly online about this topic.
- 1,823total visits
FDA warns of pure red cell aplasia (PRCA) with CellCept - MPR
empr.com —
View full resource at empr.com
Tags: Anemia, Bone, Organ Transplant Rejection Medication, Healthcare, FDA, CellCept
Most Recently Shared on August 14, 2009 at 5:41 pm By:
MPR News: FDA warns of pure red cell aplasia (PRCA) with CellCept: The FDA and Roche have notified heal.. http://bit.ly/EIAU8
Medical News: FDA Strengthens Warning on Transplant Drug - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “WASHINGTON -- A warning of a risk of pure red cell aplasia (PRCA) has been added to the label and prescribing information for mycophenolate mofetil (CellCept).” View full resource at medpagetoday.com
Most Recently Shared on August 15, 2009 at 3:33 am By:
FDA Strengthens Warning on Transplant Drug http://ow.ly/15L6sz
FDA Alert: CellCept (mycophenolate mofetil) August 2009
drugs.com — “FDA Alert: CellCept (mycophenolate mofetil) August 2009” View full resource at drugs.com
Most Recently Shared on August 15, 2009 at 2:40 am By:
FDA Alert - FDA Warns of Pure Red Cell Aplasia (PRCA) in CellCept Patients - http://bit.ly/OOw43
Advertisement
